C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro
Author:
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference66 articles.
1. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens
2. Receptor editing in lymphocyte development and central tolerance
3. B-cell anergy: from transgenic models to naturally occurring anergic B cells?
4. Predominant Autoantibody Production by Early Human B Cell Precursors
5. Defective B cell tolerance checkpoints in systemic lupus erythematosus
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost‐effectiveness of sutimlimab in cold agglutinin disease;American Journal of Hematology;2024-05-11
2. The Promise of Complement Therapeutics in Solid Organ Transplantation;Transplantation;2024-02-16
3. Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease;Journal of Clinical and Experimental Hematopathology;2023-12-26
4. Novel therapeutics and future directions for refractory immune thrombocytopenia;British Journal of Haematology;2023-09-21
5. Problem to solution; from mammalian skin grafts to renal allograft rejection: a tale of 66 years of evolution of our understanding;Journal of the Pakistan Medical Association;2023-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3